Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Growth 2019-2024

  • ID:PD041088
  • February 2019
  • LPI (LP Information)
                          

DecisionDatabases.com offers Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Research Report with market statistics and future prospect for the year 2019-2024. This report explores historical data, market share, sales, consumption, revenue and market dynamic resulting in high quality and precise data. The future trend and outlook are analyzed and compiled with the help of industry experts. This report offers different segment analysis based on global, regional and country level along with key players with their revenue, sales, and strategic development. The data is gathered and analyzed  through primary and secondary research based on expert interviews, white papers, journals and various other sources.

A biomarker is, according to the US National Institutes of Health, “a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention.”

Biomarkers make take the form of cellular characteristics, metabolites (e.g. sugars, lipids and hormones), molecular variations, or physical features (e.g., clinical symptoms) and are assessed accordingly, via measurement, annotation, documents, and images.

Increasingly, the discovery of novel biomarkers is closely associated with the advances in molecular biology techniques that can be accessed through analysis of DNA, RNA or proteins.

We can discriminate four main types of molecular biomarkers:
• Genomic biomarkers: Based on the analysis of DNA (deoxyribonucleic acid) profiles, especially the analysis of SNPs (single nucleotide polymorphisms), i.e. identification of punctual variations in genomic DNA.
• Transcriptomic biomarkers: Base on the analysis of RNA expression profiles.
• Proteomic biomarkers: Base on the analysis of the protein profiles.
• Metabolomic biomarkers: Base on the analysis of metabolites (metabolites are the intermediates and products of metabolism).

Commercializing biomarkers is the path that a biomarker could be used in therapeutic or diagnostic. In this report mainly covers consumables, services, software of this market.

In the last several years, global market of Commercializing Biomarkers in Therapeutic and Diagnostic Applications developed rapidly, with an average growth rate of 8.49%. In 2015, the consumables revenue growth rate was about 8.5%, the services revenue growth rate was nearly 8.6%, and the consumables revenue growth rate was the highest among the Commercializing Biomarkers in Therapeutic and Diagnostic Applications Industry.

North America is the largest consumer of Commercializing Biomarkers, with the sales market share nearly 42%.

The second place is Europe, following North America with the sales market share of 31%. Japan and China is also the important market, with the total sales marker share of 18.6%.

According to this study, over the next five years the Commercializing Biomarkers in Therapeutic and Diagnostic Applications market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 24400 million by 2024, from US$ 17200 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Commercializing Biomarkers in Therapeutic and Diagnostic Applications business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Commercializing Biomarkers in Therapeutic and Diagnostic Applications market by product type, application, key manufacturers and key regions and countries.

This study considers the Commercializing Biomarkers in Therapeutic and Diagnostic Applications value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

  •  Consumables
  •  Services
  •  Software
 
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
  •  Oncology
  •  Cardiology
  •  Neurology
  •  Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
  •  Americas
  •  United States
  •  Canada
  •  Mexico
  •  Brazil
  •  APAC
  •  China
  •  Japan
  •  Korea
  •  Southeast Asia
  •  India
  •  Australia
  •  Europe
  •  Germany
  •  France
  •  UK
  •  Italy
  •  Russia
  •  Spain
  •  Middle East & Africa
  •  Egypt
  •  South Africa
  •  Israel
  •  Turkey
  •  GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
  •  Roche
  •  Dako (Agilent Technologies)
  •  Merck
  •  BD
  •  Abbott
  •  Genesys Biolabs (20/20GeneSystems)
  •  Affymetrix
  •  Agendia
  •  ALMAC
  •  Arrayit
  •  Biocartic
  •  BG Medicine
  •  KEGG EXPRESSION Database
  •  Thermo Fisher
  •  BGI

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  •  To study and analyze the global Commercializing Biomarkers in Therapeutic and Diagnostic Applications consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
  •  To understand the structure of Commercializing Biomarkers in Therapeutic and Diagnostic Applications market by identifying its various subsegments.
  •  Focuses on the key global Commercializing Biomarkers in Therapeutic and Diagnostic Applications manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  •  To analyze the Commercializing Biomarkers in Therapeutic and Diagnostic Applications with respect to individual growth trends, future prospects, and their contribution to the total market.
  •  To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  •  To project the consumption of Commercializing Biomarkers in Therapeutic and Diagnostic Applications submarkets, with respect to key regions (along with their respective key countries).
  •  To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  •  To strategically profile the key players and comprehensively analyze their growth strategies.

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
 
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption 2014-2024
2.1.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption CAGR by Region
2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Segment by Type
2.2.1 Consumables
2.2.2 Services
2.2.3 Software
2.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Type
2.3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Market Share by Type (2014-2019)
2.3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue and Market Share by Type (2014-2019)
2.3.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sale Price by Type (2014-2019)
2.4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Neurology
2.4.4 Other
2.5 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Application
2.5.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Market Share by Application (2014-2019)
2.5.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value and Market Share by Application (2014-2019)
2.5.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sale Price by Application (2014-2019)
 
3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Players
3.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Players
3.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales by Players (2017-2019)
3.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales Market Share by Players (2017-2019)
3.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Players
3.2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue by Players (2017-2019)
3.2.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Revenue Market Share by Players (2017-2019)
3.3 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sale Price by Players
3.4 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Commercializing Biomarkers in Therapeutic and Diagnostic Applications Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
 
4 Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions
4.1 Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Regions
4.1.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Regions
4.1.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value by Regions
4.2 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth
4.3 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth
4.4 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth
4.5 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Growth
 
5 Americas
5.1 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Countries
5.1.1 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Countries (2014-2019)
5.1.2 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value by Countries (2014-2019)
5.2 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Type
5.3 Americas Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
 
6 APAC
6.1 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Countries
6.1.1 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Countries (2014-2019)
6.1.2 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value by Countries (2014-2019)
6.2 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Type
6.3 APAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
 
7 Europe
7.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Countries
7.1.1 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Countries (2014-2019)
7.1.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value by Countries (2014-2019)
7.2 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Type
7.3 Europe Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
 
8 Middle East & Africa
8.1 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications by Countries
8.1.1 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value by Countries (2014-2019)
8.2 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Type
8.3 Middle East & Africa Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
 
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
 
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Distributors
10.3 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Customer
 
11 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Market Forecast
11.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Consumption Forecast (2019-2024)
11.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Regions
11.2.1 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Regions (2019-2024)
11.2.2 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Type
11.8 Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Forecast by Application
 
12 Key Players Analysis
12.1 Roche
12.1.1 Company Details
12.1.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.1.3 Roche Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Roche News
12.2 Dako (Agilent Technologies)
12.2.1 Company Details
12.2.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.2.3 Dako (Agilent Technologies) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Dako (Agilent Technologies) News
12.3 Merck
12.3.1 Company Details
12.3.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.3.3 Merck Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Merck News
12.4 BD
12.4.1 Company Details
12.4.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.4.3 BD Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 BD News
12.5 Abbott
12.5.1 Company Details
12.5.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.5.3 Abbott Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Abbott News
12.6 Genesys Biolabs (20/20GeneSystems)
12.6.1 Company Details
12.6.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.6.3 Genesys Biolabs (20/20GeneSystems) Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Genesys Biolabs (20/20GeneSystems) News
12.7 Affymetrix
12.7.1 Company Details
12.7.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.7.3 Affymetrix Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Affymetrix News
12.8 Agendia
12.8.1 Company Details
12.8.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.8.3 Agendia Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Agendia News
12.9 ALMAC
12.9.1 Company Details
12.9.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.9.3 ALMAC Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 ALMAC News
12.10 Arrayit
12.10.1 Company Details
12.10.2 Commercializing Biomarkers in Therapeutic and Diagnostic Applications Product Offered
12.10.3 Arrayit Commercializing Biomarkers in Therapeutic and Diagnostic Applications Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Arrayit News
12.11 Biocartic
12.12 BG Medicine
12.13 KEGG EXPRESSION Database
12.14 Thermo Fisher
12.15 BGI
 
13 Research Findings and Conclusion

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Report 2019-2025

The Global Tigecycline Market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This report  read more..


Global Caffeine Market Research Report 2017

The Global Caffeine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost structure,  read more..


Global Rabies Vaccine Market Research Report 2017

The Global Rabies Vaccine Market Research Report provides a detailed market overview along with the analysis of industry’s gross margin, cost  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Research Report 2019

The Global Radiopharmaceuticals market report is a recent research added by DecisionDatabases.com, offers critical insight into the Market dynamic. This  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..